LAZARD ASSET MANAGEMENT LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1207017
NEW YORK, NY
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,303,259
+$3,271,309 QoQ
Shares Held
67,291
+214.0% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#68
of 264 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026LAZARD ASSET MANAGEMENT LLC holds $122,207,057 across 17 Drug Manufacturers - Specialty & Generic names. KNSA ranks #4 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
945,784 | $67,964,038 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
1,231,678 | $17,847,014 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
91,371 | $15,399,668 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
67,291 | $4,303,259 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
130,438 | $4,095,753 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
34,396 | $3,815,892 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,219 | $2,343,339 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
394,715 | $1,772,270 |
All Filings in KNSA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,303,259 | 67,291 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,031,950 | 21,432 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,787,416 | 140,301 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,370,654 | 138,312 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $420,058 | 15,181 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $63,764 | 2,871 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $61,278 | 3,098 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||